Synthesis of spirotriazolines and spirooxadiazolines <i>via</i> light-induced 1,3-dipolar [3+2] cycloadditions-Reference-Cited by-同舟云学术

Synthesis of spirotriazolines and spirooxadiazolines via light-induced 1,3-dipolar [3+2] cycloadditions

Published:2023 Issue:44 Volume:47 Page:20248-20252
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Jia Pengfei¹,Lin Zhiqian¹,Luo Cankun¹,Liang Jiao¹,Lai Ruizhi¹,Guo Li¹,Yao Yuan²,Wu Yong¹^ORCID

Affiliation:

1. Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Department of Medicinal Chemistry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, No. 17 Southern Renmin Road, Chengdu, Sichuan 610041, People's Republic of China

2. Department of Geriatrics and Cardiology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China

Abstract

We developed a strategy for the construction of spirotriazolines and spirooxadiazolines by the light-induced [3+2] cycloaddition with 2,5-diaryltetrazole. The use of light as the unique reagent is a distinguishing feature of this protocol.

Funder

Sichuan Province Science and Technology Support Program

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NJ/D3NJ03037G

Reference35 articles.

1. Synthesis of Spirocyclic Compounds by a Ring-Expansion/Cationic Cyclization Cascade Reaction of Chlorosulfate Derivatives

2. Spirocyclic Scaffolds in Medicinal Chemistry

3. Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists

4. Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate Cancer

5. Spirotriazoline oxindoles: A novel chemical scaffold with in vitro anticancer properties